DE602006014576D1 - Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate - Google Patents

Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate

Info

Publication number
DE602006014576D1
DE602006014576D1 DE602006014576T DE602006014576T DE602006014576D1 DE 602006014576 D1 DE602006014576 D1 DE 602006014576D1 DE 602006014576 T DE602006014576 T DE 602006014576T DE 602006014576 T DE602006014576 T DE 602006014576T DE 602006014576 D1 DE602006014576 D1 DE 602006014576D1
Authority
DE
Germany
Prior art keywords
sub
phenylthiazol
benzimidazol
treatment
acetamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014576T
Other languages
English (en)
Inventor
Ronald Palin
Colin Alasdair Gray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of DE602006014576D1 publication Critical patent/DE602006014576D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006014576T 2005-11-08 2006-11-06 Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate Active DE602006014576D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05110450 2005-11-08
PCT/EP2006/068109 WO2007054474A1 (en) 2005-11-08 2006-11-06 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders

Publications (1)

Publication Number Publication Date
DE602006014576D1 true DE602006014576D1 (de) 2010-07-08

Family

ID=35822427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014576T Active DE602006014576D1 (de) 2005-11-08 2006-11-06 Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate

Country Status (10)

Country Link
EP (1) EP1948650B1 (de)
JP (1) JP2009514928A (de)
CN (1) CN101351463A (de)
AT (1) ATE469148T1 (de)
AU (1) AU2006311036A1 (de)
BR (1) BRPI0618326A2 (de)
CA (1) CA2627260A1 (de)
DE (1) DE602006014576D1 (de)
ES (1) ES2344751T3 (de)
WO (1) WO2007054474A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
CN101925575B (zh) 2008-01-28 2014-06-18 株式会社爱茉莉太平洋 作为香草酸受体拮抗剂的化合物、其异构体或其药物学可接受的盐、及包含这些化合物的药物组合物
EP2307394B1 (de) 2008-07-02 2012-09-26 Amorepacific Corporation Sulfonamide als vanilloidrezeptorantagonisten
PE20120834A1 (es) * 2009-03-23 2012-07-25 Glenmark Pharmaceuticals Sa Derivados de furopirimidindiona como moduladores de trpa1
JP2018052817A (ja) * 2015-01-21 2018-04-05 大日本住友製薬株式会社 新規ベンズイミダゾール誘導体およびその医薬用途
DE102017201050A1 (de) 2017-01-24 2018-07-26 Beiersdorf Ag Wirkstoffkombinationen aus Trans-4-t-butylcyclohexanol und einem oder mehreren Alkylamidothiazolen sowie kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombinationen enthaltend

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315555T1 (de) * 2001-05-11 2006-02-15 Pfizer Prod Inc Thiazolderivate und ihre verwendung als cdk- inhibitoren
SE0301446D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds

Also Published As

Publication number Publication date
EP1948650B1 (de) 2010-05-26
ES2344751T3 (es) 2010-09-06
CN101351463A (zh) 2009-01-21
CA2627260A1 (en) 2007-05-18
JP2009514928A (ja) 2009-04-09
WO2007054474A1 (en) 2007-05-18
BRPI0618326A2 (pt) 2011-08-23
EP1948650A1 (de) 2008-07-30
AU2006311036A1 (en) 2007-05-18
ATE469148T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
ATE384058T1 (de) Thiazolderivate
PE20090837A1 (es) Nuevos compuestos quimicos
EA200500304A1 (ru) Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
WO2004087699A3 (en) Thiazoles useful as inhibitors of protein kinases
WO2004087698A3 (en) Thiazoles useful as inhibitors of protein kinases
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
ME00954B (me) Aminoheterociklični spojevi
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA200400892A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
DE602006009080D1 (de) 1-essigsäureindolderivate mit pgd2-antagonistischer wirkung
EA200601287A1 (ru) Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE480239T1 (de) Angiogeneseinhibitoren
ATE469148T1 (de) Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol- 1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
SE0302324D0 (sv) Novel compounds
CL2003002769A1 (es) Compuestos derivados de carboxamida de tiazolilpirrol; procedimiento para su preparacion; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento y/o profilaxis de enfermedades asociadas con la modulacion de receptores canabinoid
SE0302323D0 (sv) Novel compounds
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
SE0302756D0 (sv) Novel Compounds
WO2006079556A3 (en) Substituted 5-phenyl pyrimidines i in therapy

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1948650

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE